PCSK9 can bind to TLRs, increase the levels of P-IκBα, IkBα degradation, and NF-κB nuclear translocation in macrophages, regulate the microenvironment of myocardial inflammation, and influence the course of cardiovascular disease. Here, NFKBIA is linked to cardiovascular disorder.